Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis

Background. Two preparations of botulinum A toxin (BTX-A) are commercially available for the treatment of palmar hyperhidrosis (PPH): Botox (Allergan; 100 U/vial) and Dysport (Ipsen Limited; 500 U/vial), which are not bioequivalent. Results regarding an appropriate conversion factor between them are...

Descripción completa

Detalles Bibliográficos
Autores principales: El Kahky, Hanan Mohamed, Diab, Heba Mahmoud, Aly, Dalia Gamal, Farag, Nehal Magdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819791/
https://www.ncbi.nlm.nih.gov/pubmed/24250334
http://dx.doi.org/10.1155/2013/686329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3819791/
https://www.ncbi.nlm.nih.gov/pubmed/24250334
http://dx.doi.org/10.1155/2013/686329

Ejemplares similares